11 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18631588 | CLEVIDIPINE EMULSION FORMULATIONS CONTAINING ANTIMICROBIAL AGENTS | ARNOLD, ERNST V | 1613 | Non-Final OA | Apr 10, 2024 |
| 18283855 | INDOLINE DERIVATIVES AS DDR1 AND DDR2 INHIBITORS | NOTTINGHAM, KYLE GREGORY | 1621 | Non-Final OA | Sep 25, 2023 |
| 18283529 | COMBINED TREATMENT OF BRAIN INJURY | KATAKAM, SUDHAKAR | 1658 | Non-Final OA | Sep 22, 2023 |
| 18282068 | HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS | LEE, CHIHYI NMN | 1628 | Non-Final OA | Sep 14, 2023 |
| 18282096 | HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS | DAHLIN, HEATHER RAQUEL | 1629 | Non-Final OA | Sep 14, 2023 |
| 18282079 | HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS | DAHLIN, HEATHER RAQUEL | 1629 | Non-Final OA | Sep 14, 2023 |
| 18269042 | PYRIDO OXAZINE DERIVATIVES AS ALK5 INHIBITORS | RICCI, CRAIG D | 1611 | Non-Final OA | Jun 22, 2023 |
| 18267185 | DIHYDROFUROPYRIDINE DERIVATIVES AS RHO-KINASE INHIBITORS | CHANDRAKUMAR, NIZAL S | 1625 | Non-Final OA | Jun 14, 2023 |
| 17927762 | BENZYLAMINE DERIVATIVES AS DDRS INHIBITORS | STOCKTON, LAURA LYNNE | 1626 | Final Rejection | Nov 25, 2022 |
| 17801067 | PRESSURISED METERED DOSE INHALERS COMPRISING A BUFFERED PHARMACEUTICAL FORMULATION | JANG, JAEICK | 3785 | Final Rejection | Aug 19, 2022 |
| 17760354 | PRESSURED METERED DOSE INHALERS COMPRISING A BUFFERED PHARMACEUTICAL FORMULATION | HAGHIGHATIAN, MINA | 1616 | Non-Final OA | Aug 08, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial